NO20074723L - Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjon - Google Patents

Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjon

Info

Publication number
NO20074723L
NO20074723L NO20074723A NO20074723A NO20074723L NO 20074723 L NO20074723 L NO 20074723L NO 20074723 A NO20074723 A NO 20074723A NO 20074723 A NO20074723 A NO 20074723A NO 20074723 L NO20074723 L NO 20074723L
Authority
NO
Norway
Prior art keywords
substituted
group
antifungal
useful
fungal infection
Prior art date
Application number
NO20074723A
Other languages
English (en)
Other versions
NO339713B1 (no
Inventor
Nobuhiko Nomura
Hiroshi Nishikawa
Noritomo Fujino
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO20074723L publication Critical patent/NO20074723L/no
Publication of NO339713B1 publication Critical patent/NO339713B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasøytisk preparat inneholdende én eller flere antisoppmidler valgt fra et arylamidinderivat representert ved den generelle formel: [Kjemisk Formel 1] (hvor R1 representerer en amidino-gruppe som kan være substituert med en hydroksylgruppe som kan beskyttes med en acylgruppe, en amidin-gruppe som kan være substituert med en alkoksygruppe som kan være substituert eller en amidin-gruppe som kan være substituert med en aralkyloksygruppe som kan være substituert; R2 og R3 like eller forskjellige representerer et hydrogenatom eller et halogenatom) eller et salt derav, et azol antisoppmiddel, et polyen antisoppmiddel, et candin antisoppmiddel og et fluorpyrimidin antisoppmiddel har en sterk antisopp aktivitet og er anvendelige for behandling av soppinfeksjon. En metode for anvendelse av dem i kombinasjon er anvendelige som en utmerket terapeutisk metode for soppinfeksjon. Farmasøytisk preparat inneholdende arylamidinderivatet representert ved kjemisk formel 1 eller et salt derav og et immunosuppressivt middel har en sterk antisopp aktivitet og er anvendelige for behandling av soppinfeksjon og en hudsykdom så som atopisk dermatitt. En metode for anvendelse av dem i kombinasjon er anvendelig som en utmerket terapeutisk metode for soppinfeksjon og en hudsykdom så som atopisk dermatitt.
NO20074723A 2005-04-07 2007-09-17 Arylamidinderivater og farmasøytisk preparat inneholdende samme for anvendelse i soppmidler i kombinasjon NO339713B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005110784 2005-04-07
PCT/JP2006/307204 WO2006109642A1 (ja) 2005-04-07 2006-04-05 医薬組成物および抗真菌剤を組み合わせて使用する方法

Publications (2)

Publication Number Publication Date
NO20074723L true NO20074723L (no) 2007-12-28
NO339713B1 NO339713B1 (no) 2017-01-23

Family

ID=37086920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074723A NO339713B1 (no) 2005-04-07 2007-09-17 Arylamidinderivater og farmasøytisk preparat inneholdende samme for anvendelse i soppmidler i kombinasjon

Country Status (19)

Country Link
US (1) US8993603B2 (no)
EP (1) EP1867332B1 (no)
JP (1) JP5216323B2 (no)
KR (1) KR101325620B1 (no)
CN (1) CN101151032B (no)
AU (1) AU2006234228B2 (no)
BR (1) BRPI0607910A2 (no)
CA (1) CA2602121C (no)
CY (1) CY1111983T1 (no)
DK (1) DK1867332T3 (no)
ES (1) ES2368078T3 (no)
NO (1) NO339713B1 (no)
NZ (1) NZ561675A (no)
PL (1) PL1867332T3 (no)
PT (1) PT1867332E (no)
RU (1) RU2396955C2 (no)
SI (1) SI1867332T1 (no)
WO (1) WO2006109642A1 (no)
ZA (1) ZA200708530B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ564759A (en) * 2005-06-30 2011-08-26 Prosidion Ltd GPCR agonists
CN101351204B (zh) * 2005-12-29 2011-01-12 富山化学工业株式会社 芳脒衍生物及其盐、以及含有它们的抗真菌药
MX2009003533A (es) * 2006-10-06 2009-07-17 Toyama Chemical Co Ltd Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico.
TWI544924B (zh) * 2010-09-30 2016-08-11 富山化學工業股份有限公司 經皮吸收製劑
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
US20160128944A1 (en) 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
KR101658365B1 (ko) 2015-06-10 2016-09-22 주식회사 케어사이드 피부 감염의 예방 및 치료용 조성물
CN109689028A (zh) * 2016-07-12 2019-04-26 马丁尼斯生物制药纳米技术公司 用于中枢神经系统递送和治疗隐球菌感染的脂质卷包封的抗真菌化合物
WO2019118527A1 (en) * 2017-12-14 2019-06-20 The Johns Hopkins University Novel anti-fungal inhibitors
CN110269939A (zh) * 2019-03-12 2019-09-24 武汉愔紫生物科技有限公司 一种治疗真菌分泌蛋白介导的炎症疾病标志物的药物、药物组合物、用途及其使用方法
CN114126609B (zh) * 2019-07-11 2024-01-02 株式会社赛轮制药 原藻病的新型治疗剂
BR112022024697A2 (pt) 2020-06-03 2023-03-07 Ishihara Sangyo Kaisha Agente antimicrobiano para animal não humano

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939292A1 (de) 1979-09-28 1981-04-09 Boehringer Mannheim Gmbh, 6800 Mannheim N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
JP2865722B2 (ja) 1989-08-14 1999-03-08 日産自動車株式会社 カチオン電着塗料組成物
JPH03288051A (ja) 1990-03-30 1991-12-18 Mazda Motor Corp カムシャフトおよびその製造方法
GB9509631D0 (en) 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
CZ88499A3 (cs) * 1996-09-12 1999-10-13 Merck And Co., Inc. Kombinace látek s antifungálním účinkem
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
NZ534962A (en) * 2002-03-06 2005-07-29 Toyama Chemical Co Ltd Novel arylamidine derivative or salt thereof
JP4937506B2 (ja) 2003-09-05 2012-05-23 富山化学工業株式会社 新規なアリールアミジン誘導体またはその塩
EP1767526B1 (en) * 2004-06-30 2012-10-24 Toyama Chemical Co., Ltd. Arylamidine derivative, salt thereof and antifungal containing these

Also Published As

Publication number Publication date
AU2006234228B2 (en) 2011-05-26
ES2368078T3 (es) 2011-11-14
PT1867332E (pt) 2011-11-03
WO2006109642A1 (ja) 2006-10-19
KR20080002854A (ko) 2008-01-04
US8993603B2 (en) 2015-03-31
DK1867332T3 (da) 2011-09-19
CN101151032A (zh) 2008-03-26
CA2602121A1 (en) 2006-10-19
AU2006234228A1 (en) 2006-10-19
KR101325620B1 (ko) 2013-11-06
RU2007141162A (ru) 2009-05-20
BRPI0607910A2 (pt) 2010-03-23
CY1111983T1 (el) 2015-11-04
EP1867332A1 (en) 2007-12-19
NZ561675A (en) 2010-07-30
EP1867332B1 (en) 2011-08-24
JP5216323B2 (ja) 2013-06-19
CN101151032B (zh) 2011-06-22
SI1867332T1 (sl) 2011-11-30
PL1867332T3 (pl) 2012-01-31
CA2602121C (en) 2014-09-23
RU2396955C2 (ru) 2010-08-20
US20090087480A1 (en) 2009-04-02
NO339713B1 (no) 2017-01-23
ZA200708530B (en) 2009-04-29
EP1867332A4 (en) 2010-01-27
JPWO2006109642A1 (ja) 2008-11-13

Similar Documents

Publication Publication Date Title
NO20062726L (no) Nye pyridazin-3(2H)-on derivater
NO20070432L (no) Pyrimidinureaderivater som kinaseinhibitorer
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
NO20073719L (no) Kjemiske forbindelser
NO20062704L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
WO2008016738A3 (en) Antibacterial agents and related screening methods using small molecule macroarrays
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20082709L (no) Kjemiske forbindelser
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
NO20055688L (no) Organiske forbindelser
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
UA95796C2 (ru) Производные n-циклопропил-бензиламида, способ их получения, фунгицидная композиция и способ борьбы с фитопатогенными грибами
NO20083542L (no) Nye kumarinderivater med antitumoraktivitet
NO20054220L (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20071109L (no) Indol-2-karboksamidinderivater som NMDA-reseptorantagonister
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
NO20061743L (no) Kinazolinderivater
NO20081217L (no) Nye benzotiazolonderivater
NO20076357L (no) Azabicykliske heterocykler som cannabinoid reseptor modulatorer
WO2009016218A3 (en) Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
NO20056192L (no) Kapaseinhibitorer og anvendelse derav

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: FUJIFILM TOYAMA CHEMICAL CO., JP

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: APPILI THERAPEUTICS INC., CA